DYAI — Dyadic International Share Price
0.000.00%
Last trade - 00:00- $36.08m
- $31.80m
- $3.50m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 14.61 | ||
| Price to Tang. Book | 14.61 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 10.32 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -78.03% | ||
| Return on Equity | -139.16% | ||
| Operating Margin | -167.03% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.6 | 2.4 | 2.93 | 2.9 | 3.5 | 7.45 | 5.5 | 15.77% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica, which the Company named C1. The Compny’s lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.
Directors
- Michael Tarnok NEC (66)
- Mark Emalfarb PRE (65)
- Ping Rawson CFO (45)
- Ronen Tchelet VRD (63)
- Matthew Jones MDR (43)
- Joseph Hazelton OTH (46)
- Arindam Bose IND (68)
- Barry Buckland IND (73)
- Seth Herbst IND (63)
- Jack Kaye IND (77)
- Patrick Lucy IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 23rd, 2002
- Public Since
- November 5th, 2004
- No. of Shareholders
- 47
- No. of Employees
- 6
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 30,090,661
- Address
- 1044 NORTH U.S. HIGHWAY ONE, SUITE 201, JUPITER, 33477
- Web
- https://dyadic.com/
- Phone
- +1 5617438333
- Auditors
- Crowe LLP
Upcoming Events for DYAI
Q1 2025 Dyadic International Inc Earnings Call
Dyadic International Inc Annual Shareholders Meeting
Dyadic International Inc Annual Shareholders Meeting
Q2 2025 Dyadic International Inc Earnings Release
Similar to DYAI
Abeona Therapeutics
NASDAQ Capital Market
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
FAQ
What is the Dyadic International share price?
As of Today at 20:20 UTC, shares in Dyadic International are trading at $1.20. This share price information is delayed by 15 minutes.
How has the Dyadic International share price performed this year?
Shares in Dyadic International last closed at $1.20 and the price had moved by -20.05% over the past 365 days. In terms of relative price strength the Dyadic International share price has underperformed the S&P500 Index by -27.91% over the past year.
What are the analyst and broker recommendations for Dyadic International?
The overall consensus recommendation for Dyadic International is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Dyadic International dividend yield?
Dyadic International does not currently pay a dividend.
Does Dyadic International pay a dividend?
Dyadic International does not currently pay a dividend.
When does Dyadic International next pay dividends?
Dyadic International does not currently pay a dividend.
How do I buy Dyadic International shares?
To buy shares in Dyadic International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Dyadic International?
As of the previous close price of $1.20, shares in Dyadic International had a market capitalisation of $36.08m.
Where are Dyadic International shares listed?
Here are the trading details for Dyadic International:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: DYAI
What kind of share is Dyadic International?
Based on an overall assessment of its quality, value and momentum Dyadic International is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Dyadic International share price forecast for 2025?
The analyst consensus target price for shares in Dyadic International is $9.00. That is 650.5% above the last closing price of $1.20.
Analysts covering Dyadic International currently have a consensus Earnings Per Share (EPS) forecast of -$0.19 for the next financial year.
Find out moreWhat is the trend in the Dyadic International share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dyadic International. Over the past six months, its share price has outperformed the S&P500 Index by +13.65%.
As of the last closing price of $1.20, shares in Dyadic International were trading -13.05% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Dyadic International PE Ratio?
The Dyadic International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Dyadic International?
Dyadic International's management team is headed by:
- Michael Tarnok - NEC
- Mark Emalfarb - PRE
- Ping Rawson - CFO
- Ronen Tchelet - VRD
- Matthew Jones - MDR
- Joseph Hazelton - OTH
- Arindam Bose - IND
- Barry Buckland - IND
- Seth Herbst - IND
- Jack Kaye - IND
- Patrick Lucy - IND